Global X Japan Co. Ltd. Makes New Investment in Astera Labs, Inc. $ALAB

Global X Japan Co. Ltd. acquired a new stake in Astera Labs, Inc. (NASDAQ:ALAB) during the fourth quarter, HoldingsChannel reports. The firm acquired 9,328 shares of the company’s stock, valued at approximately $1,552,000.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. CoreCap Advisors LLC increased its stake in Astera Labs by 83.0% in the fourth quarter. CoreCap Advisors LLC now owns 1,334 shares of the company’s stock valued at $222,000 after purchasing an additional 605 shares during the last quarter. Paragon Advisors LLC lifted its position in shares of Astera Labs by 79.1% during the 4th quarter. Paragon Advisors LLC now owns 16,732 shares of the company’s stock worth $2,784,000 after buying an additional 7,390 shares during the last quarter. Wealth Management Partners LLC boosted its holdings in shares of Astera Labs by 25.6% in the 4th quarter. Wealth Management Partners LLC now owns 32,755 shares of the company’s stock valued at $5,449,000 after buying an additional 6,678 shares in the last quarter. E. Ohman J or Asset Management AB acquired a new position in shares of Astera Labs in the 4th quarter valued at $550,000. Finally, Avanza Fonder AB purchased a new position in shares of Astera Labs in the 4th quarter valued at $857,000. 60.47% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities research analysts recently weighed in on the stock. Morgan Stanley reissued an “overweight” rating and issued a $210.00 price target on shares of Astera Labs in a research report on Wednesday, December 3rd. Barclays set a $165.00 target price on Astera Labs in a research report on Thursday, January 15th. Loop Capital began coverage on Astera Labs in a research note on Thursday, March 5th. They set a “buy” rating and a $250.00 price target on the stock. Royal Bank Of Canada began coverage on Astera Labs in a research note on Wednesday, January 14th. They issued an “outperform” rating and a $225.00 price objective for the company. Finally, Jefferies Financial Group reissued a “buy” rating on shares of Astera Labs in a report on Wednesday, December 3rd. Fifteen investment analysts have rated the stock with a Buy rating, six have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $202.22.

Insider Activity at Astera Labs

In other Astera Labs news, General Counsel Philip Mazzara sold 10,000 shares of the business’s stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $117.47, for a total transaction of $1,174,700.00. Following the sale, the general counsel directly owned 128,084 shares in the company, valued at approximately $15,046,027.48. The trade was a 7.24% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Jitendra Mohan sold 157,500 shares of the firm’s stock in a transaction on Tuesday, March 17th. The shares were sold at an average price of $131.58, for a total value of $20,723,850.00. Following the completion of the transaction, the chief executive officer owned 4,531,732 shares of the company’s stock, valued at approximately $596,285,296.56. This represents a 3.36% decrease in their position. The SEC filing for this sale provides additional information. In the last ninety days, insiders sold 384,292 shares of company stock worth $48,724,919. 12.50% of the stock is currently owned by insiders.

Astera Labs Stock Down 5.6%

NASDAQ ALAB opened at $113.61 on Friday. The firm has a market cap of $19.46 billion, a P/E ratio of 93.12, a P/E/G ratio of 2.37 and a beta of 1.74. Astera Labs, Inc. has a 52-week low of $47.13 and a 52-week high of $262.90. The business’s 50-day moving average price is $139.69 and its 200 day moving average price is $164.44.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings results on Tuesday, February 10th. The company reported $0.58 EPS for the quarter, topping the consensus estimate of $0.51 by $0.07. The business had revenue of $270.58 million during the quarter, compared to analysts’ expectations of $249.46 million. Astera Labs had a return on equity of 16.12% and a net margin of 25.70%.The company’s quarterly revenue was up 91.8% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.37 earnings per share. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. As a group, analysts anticipate that Astera Labs, Inc. will post 0.34 earnings per share for the current year.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.